<?xml version="1.0" encoding="UTF-8"?>
<ref id="R12">
 <label>12</label>
 <mixed-citation publication-type="journal">
  <string-name>
   <surname>Carballo-Arce</surname>
   <given-names>AF</given-names>
  </string-name>, 
  <string-name>
   <surname>Raina</surname>
   <given-names>V</given-names>
  </string-name>, 
  <string-name>
   <surname>Liu</surname>
   <given-names>S</given-names>
  </string-name>, 
  <string-name>
   <surname>Liu</surname>
   <given-names>R</given-names>
  </string-name>, 
  <string-name>
   <surname>Jackiewicz</surname>
   <given-names>V</given-names>
  </string-name>, 
  <string-name>
   <surname>Carranza</surname>
   <given-names>D</given-names>
  </string-name>, 
  <string-name>
   <surname>Arnason</surname>
   <given-names>JT</given-names>
  </string-name>, 
  <string-name>
   <surname>Durst</surname>
   <given-names>T</given-names>
  </string-name>. 
  <year>2019</year>. 
  <article-title>Potent CYP3A4 inhibitors derived from dillapiol and sesamol</article-title>. 
  <source>ACS Omega</source>, 
  <volume>4</volume>, 
  <fpage>10915</fpage>â€“
  <lpage>10920</lpage>.
  <pub-id pub-id-type="pmid">31460189</pub-id>
 </mixed-citation>
</ref>
